z-logo
Premium
Outcomes of newly diagnosed idiopathic generalized epilepsy syndromes in a non‐pediatric setting
Author(s) -
Mohanraj R.,
Brodie M. J.
Publication year - 2007
Publication title -
acta neurologica scandinavica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.967
H-Index - 95
eISSN - 1600-0404
pISSN - 0001-6314
DOI - 10.1111/j.1600-0404.2006.00791.x
Subject(s) - juvenile myoclonic epilepsy , idiopathic generalized epilepsy , lamotrigine , medicine , epilepsy , pediatrics , generalized epilepsy , cohort , family history , epilepsy syndromes , myoclonic epilepsy , levetiracetam , cohort study , psychiatry
 –  The prognosis of idiopathic generalized epilepsy syndromes (IGES) in the adult setting may vary from that in children owing to differences in genetic, environmental and lifestyle factors. Methods –  All patients diagnosed with epilepsy at the Epilepsy Unit, Western Infirmary, Glasgow, between 1981 and 2001 were reviewed. Results –  Of 890 patients, 118 (13%) met the criteria for IGES. Outcomes were known for 103, 66 (64%) of whom achieved remission. The responder rate with sodium valproate was superior (66% vs 45%, P  = 0.073) to that with lamotrigine (LTG) particularly in patients with juvenile myoclonic epilepsies (75% vs 39%, P  = 0.014). History of febrile seizures was the only factor associated with reduced likelihood of remission ( P  = 0.032) Conclusions –  Idiopathic generalized epilepsy syndromes constituted 13% of cases in a largely adult cohort of newly diagnosed epilepsy, most of whom achieved remission usually with a single antiepileptic drug. History of febrile seizures was associated with a poorer outcome.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom